SARS-CoV-2 infects human brain organoids causing cell death and loss of synapses that can be rescued by treatment with Sofosbuvir.
The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is the causative agent of coronavirus disease 2019 (COVID-19), which was rapidly declared a pandemic by the World Health Organization (WHO). Early clinical symptomatology focused mainly on respiratory illnesses. However, a variety of n...
Main Authors: | Pinar Mesci, Janaina S de Souza, Laura Martin-Sancho, Angela Macia, Aurian Saleh, Xin Yin, Cedric Snethlage, Jason W Adams, Simoni H Avansini, Roberto H Herai, Angels Almenar-Queralt, Yuan Pu, Ryan A Szeto, Gabriela Goldberg, Patrick T Bruck, Fabio Papes, Sumit K Chanda, Alysson R Muotri |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2022-11-01
|
Series: | PLoS Biology |
Online Access: | https://doi.org/10.1371/journal.pbio.3001845 |
Similar Items
-
SARS-CoV-2 infects human brain organoids causing cell death and loss of synapses that can be rescued by treatment with Sofosbuvir
by: Pinar Mesci, et al.
Published: (2022-11-01) -
Applications of human brain organoids
by: Alysson Renato Muotri
Published: (2022-06-01) -
Recent advancements and future requirements in vascularization of cortical organoids
by: Erin LaMontagne, et al.
Published: (2022-11-01) -
Editorial: Advances in iPSC technology for disease modeling and therapeutic applications
by: Methichit Wattanapanitch, et al.
Published: (2023-07-01) -
Neural Stimulation of Brain Organoids with Dynamic Patterns: A Sentiomics Approach Directed to Regenerative Neuromedicine
by: Alfredo Pereira, et al.
Published: (2023-01-01)